tiprankstipranks
Qualigen Therapeutics Inc (QLGN)
NASDAQ:QLGN
Holding QLGN?
Track your performance easily

Qualigen Therapeutics (QLGN) Financial Statements

634 Followers

Qualigen Therapeutics Financial Overview

Qualigen Therapeutics's market cap is currently ―. The company's EPS TTM is $-55.297; its P/E ratio is -0.07; Qualigen Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue----$ 1.63M
Gross Profit----$ 610.49K
EBIT$ -1.77M$ -1.73M$ -1.89M$ -1.92M$ -3.60M
EBITDA$ -1.77M$ -1.73M$ -1.89M$ -1.92M$ -3.60M
Net Income Common Stockholders$ -1.82M$ -1.58M$ -2.09M$ -2.45M$ -3.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 388.15K$ 118.69K$ 100.00K$ 400.00K$ 1.30M
Total Assets$ 2.31M$ 534.41K$ 1.00M$ 2.03M$ 13.15M
Total Debt$ 0.00$ 0.00$ 1.02M$ 1.30M$ 3.20M
Net Debt$ -388.15K$ -118.69K$ 922.87K$ 899.22K$ 1.90M
Total Liabilities$ 2.48M$ 3.10M$ 4.52M$ 4.14M$ 9.84M
Stockholders Equity$ -2.14M$ -4.28M$ -3.49M$ -2.10M$ 2.03M
Cash Flow-
Free Cash Flow$ -1.80M$ -1.47M$ -783.59K$ -5.67M$ -2.93M
Operating Cash Flow$ -1.80M$ -1.47M$ -783.59K$ -5.67M$ -2.93M
Investing Cash Flow$ -1.25M$ 350.00K-$ 235.40K$ -48.41K
Financing Cash Flow$ 3.32M$ 1.15M$ 475.00K$ -110.00K-
Currency in USD

Qualigen Therapeutics Earnings and Revenue History

Qualigen Therapeutics Debt to Assets

Qualigen Therapeutics Cash Flow

Qualigen Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis